Esperion Therapeutics Inc (ESPR)
Total Liabilities
$770.46M
Quarterly · Period ending: · USD
ESPR Total Liabilities
Latest reported$770.46Mperiod ending
Latest reported$770.46Mperiod ending
ESPR Quarterly Total Liabilities ($5.40M → $770.46M)
Quarterly total liabilities
High-resolution chart · PNG
ESPR total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 770,460,000 | |
| 767,851,000 | |
| 815,381,000 | |
| 780,594,000 | |
| 750,240,000 | |
| 732,543,000 | |
| 684,323,000 | |
| 696,539,000 | |
| 667,358,000 | |
| 660,790,000 | |
| 631,309,000 | |
| 606,604,000 | |
| 581,482,000 | |
| 571,717,000 | |
| 606,927,000 | |
| 595,678,000 | |
| 591,893,000 | |
| 578,534,000 | |
| 587,961,000 | |
| 584,771,000 | |
| 548,000,000 | |
| 449,392,000 | |
| 242,009,000 | |
| 244,863,000 | |
| 229,888,000 | |
| 194,497,000 | |
| 186,758,000 | |
| 179,480,000 | |
| 61,472,000 | |
| 64,333,000 | |
| 42,285,000 | |
| 34,964,000 | |
| 30,048,000 | |
| 33,144,000 | |
| 34,997,000 | |
| 31,135,000 | |
| 22,190,000 | |
| 16,611,000 | |
| 9,611,000 | |
| 9,506,000 | |
| 8,276,000 | |
| 8,313,000 | |
| 9,912,000 | |
| 10,502,000 | |
| 10,794,000 | |
| 9,790,000 | |
| 10,307,000 | |
| 10,378,000 | |
| 3,188,000 | |
| 4,202,491 | |
| 3,342,956 | |
| 6,644,425 | |
| 2,521,249 | |
| 24,702,144 | |
| 14,372,000 | |
| 14,480,000 | |
| 12,679,000 | |
| 12,664,000 | |
| 12,026,000 | |
| 12,535,000 | |
| 12,789,000 | |
| 11,842,000 | |
| 12,206,000 | |
| 11,879,000 | |
| 9,972,000 | |
| 10,186,000 | |
| 10,020,000 | |
| 7,345,000 | |
| 5,403,580 |